Developer docs
API playgroundTry for free, no card

Search company profiles

GQ Life Sciences

Full company profile

uuid000b6or

Namestring
GQ Life Sciences
Company typeenum
Private
Founded yearint
2001
Descriptiontext

GQ Life Sciences, Inc. was a Boston-based private life science information and search company founded in 2001 that built GenomeQuest, a specialized enterprise software platform for biological sequence intellectual property search. The platform aggregated a database of more than 694 million sequences spanning both patent and non-patent sources and provided specialized search tools including Enhanced Keyword in Context and SEQ ID Highlighting, enabling comprehensive prior art, patent novelty, and freedom-to-operate analysis for biological IP. The company served three primary vertical segments: pharmaceutical and biotechnology companies requiring IP sequence search for drug development and R&D protection; government patent offices (including IP Australia, IP New Zealand, Danish Patent Office, and Norwegian Industrial Property Office) requiring sequence search for patent examination; and IP law firms and legal service providers (including Cooley, Fish & Richardson, Choate Hall & Stewart, Wolf Greenfield, and others) supporting patent prosecution and litigation.

The company operated an enterprise software licensing revenue model based on recurring subscription contracts with annual billing cadence, supported by a global enterprise field sales motion with quote-based pricing accessible only through 'Request a demo' and 'Request pricing' engagements. The company was funded through three disclosed rounds between 2005 and 2009 totaling approximately $11.2M from investors including Cross Atlantic Capital Partners, Mosaix Ventures, Activate Venture Partners, and Societe Generale Asset Management. GQ Life Sciences was acquired by Aptean, a strategic operating company in vertical enterprise software, with the GenomeQuest product rebranded as Aptean GenomeQuest and integrated into Aptean's IP Search solutions portfolio. Following the acquisition, the company no longer operates as an independent entity; the original gqlifesciences.com domain redirects to the Aptean product page.

Short descriptiontext

GQ Life Sciences built GenomeQuest, an enterprise biological IP search platform covering 694+ million patent and non-patent sequences, serving pharmaceutical companies, government patent offices, and IP law firms. The company was acquired by Aptean and now operates as Aptean GenomeQuest.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
biological IP search, sequence patent search, genome prior art, bioinformatics software, patent sequence database
Industry4 codes
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAJAN
Knowledge Management & Scientific Collaboration / Literature Intelligence
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code3 codes
  • Software Publishers5132
  • Web Search Portals and All Other Information Services51929
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Biological IP Search Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Enterprise Software Licensing
TypeSubscription Recurring
Description

Enterprise software licensing model for IP sequence search solution targeting pharmaceutical, biotechnology, and IP law organizations.

aptean.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Quote-based enterprise pricing
ModelSubscriptionBilling cadenceAnnual
Notes

No public pricing tiers disclosed. Contact sales for demo and pricing information.

aptean.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

GQ Life Sciences develops and licenses GenomeQuest (now Aptean GenomeQuest), an enterprise biological IP search platform that indexes 694+ million sequences from both patent and non-patent sources. The software enables pharmaceutical, biotechnology, patent office, and IP law firm users to conduct comprehensive sequence-domain prior art, novelty, and freedom-to-operate searches with features such as Enhanced Keyword in Context and SEQ ID Highlighting.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 694+ million sequences in database
Product overview1 text field

GQ Life Sciences redirects to Aptean GenomeQuest, a single unified product offering for comprehensive biological IP sequence search. The platform provides access to 694+ million sequences across patent and non-patent databases, featuring enhanced keyword context display and sequence ID highlighting capabilities.

Product and service1 record
1Aptean GenomeQuest (formerly GenomeQuest)
CategoryBiological IP Search Software
Description

Enterprise biological IP search platform providing comprehensive sequence-domain searching across 694+ million patent and non-patent sequences. Used by pharmaceutical and biotechnology companies, government patent offices, and IP law firms for prior art, novelty, freedom-to-operate, and patent validity analysis. Features include Enhanced Keyword in Context and SEQ ID Highlighting.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1WIPO PATENTSCOPE
TypeOthers
Description

WIPO PATENTSCOPE is the international patent application's global search portal operated by the World Intellectual Property Organization. It is an adjacent ecosystem participant: a free public search tool that patent offices (including GenomeQuest customers) use alongside commercial platforms.

TypeDirect peer
Description

Minesoft provides PatentHub, PatBase, and MinePat enterprise patent search solutions serving patent attorneys, examiners, and corporate IP teams. It is a direct enterprise peer to GenomeQuest in the IP prior-art search category.

TypeDirect peer
Description

Questel offers Orbit Intelligence, an enterprise patent search and analytics suite directly comparable to GenomeQuest's biological IP search capabilities. Both serve IP attorneys, patent offices, and life sciences R&D teams with subscription-based prior-art and freedom-to-operate tools.

TypeDirect peer
Description

PatSnap is an AI-powered IP and R&D intelligence platform covering patents, sequences, and innovation analytics. It competes directly with GenomeQuest in pharma/biotech IP workflows and adds an emerging AI/ML layer that overlaps with GenomeQuest's prior-art and sequence-search use cases.

TypeEmerging player
Description

SureChem (part of Digital Science) provides chemical patent search and structure-based IP analytics. It is an emerging player in the IP search market that overlaps with GenomeQuest's life sciences patent search focus, particularly for chemistry-adjacent biotech IP.

6GeneCards
TypeEmerging player
Description

GeneCards is a comprehensive bioinformatics database of human genes maintained by the Weizmann Institute. It is an emerging, niche bioinformatics player adjacent to GenomeQuest's biological information focus, but does not target the IP/patent workflow directly.

TypeBroad incumbent
Description

Clarivate is the dominant IP intelligence and scientific analytics platform (Derwent World Patents Index, PatentSight, Cortellis). It is a broad incumbent that competes with GenomeQuest across patent prior-art search and biotech IP analytics, but at significantly larger scale and a broader portfolio.

8CAS (Chemical Abstracts Service)
TypeBroad incumbent
Description

CAS, a division of ACS, provides SciFinder-n and related scientific information platforms with deep coverage of chemical, biological, and patent literature. It overlaps with GenomeQuest in serving pharma/biotech IP professionals searching large scientific corpora for prior art.

TypeEmerging player
Description

NCBI BLAST is the public-domain standard for biological sequence similarity search maintained by the National Library of Medicine. It is not focused on patent prior-art, but represents the baseline sequence search tool against which GenomeQuest's IP-enriched patent/non-patent corpus competes.

TypeBroad incumbent
Description

LexisNexis IP (PatentAdvisor, PatentSight via Clarivate partnership, TotalPatent) provides patent search and analytics solutions to IP law firms and patent offices. It overlaps with GenomeQuest in freedom-to-operate, validity, and prior-art search workflows.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers25 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GQ Life Sciences

Biological IP Search Softwaregqlifesciences.com

GQ Life Sciences built GenomeQuest, an enterprise biological IP search platform covering 694+ million patent and non-patent sequences, serving pharmaceutical companies, government patent offices, and IP law firms. The company was acquired by Aptean and now operates as Aptean GenomeQuest.

What GQ Life Sciences does

GQ Life Sciences, Inc. was a Boston-based private life science information and search company founded in 2001 that built GenomeQuest, a specialized enterprise software platform for biological sequence intellectual property search. The platform aggregated a database of more than 694 million sequences spanning both patent and non-patent sources and provided specialized search tools including Enhanced Keyword in Context and SEQ ID Highlighting, enabling comprehensive prior art, patent novelty, and freedom-to-operate analysis for biological IP. The company served three primary vertical segments: pharmaceutical and biotechnology companies requiring IP sequence search for drug development and R&D protection; government patent offices (including IP Australia, IP New Zealand, Danish Patent Office, and Norwegian Industrial Property Office) requiring sequence search for patent examination; and IP law firms and legal service providers (including Cooley, Fish & Richardson, Choate Hall & Stewart, Wolf Greenfield, and others) supporting patent prosecution and litigation.

The company operated an enterprise software licensing revenue model based on recurring subscription contracts with annual billing cadence, supported by a global enterprise field sales motion with quote-based pricing accessible only through 'Request a demo' and 'Request pricing' engagements. The company was funded through three disclosed rounds between 2005 and 2009 totaling approximately $11.2M from investors including Cross Atlantic Capital Partners, Mosaix Ventures, Activate Venture Partners, and Societe Generale Asset Management. GQ Life Sciences was acquired by Aptean, a strategic operating company in vertical enterprise software, with the GenomeQuest product rebranded as Aptean GenomeQuest and integrated into Aptean's IP Search solutions portfolio. Following the acquisition, the company no longer operates as an independent entity; the original gqlifesciences.com domain redirects to the Aptean product page.

GQ Life Sciences firmographics

Firmographics
Name
GQ Life Sciences
Website
https://gqlifesciences.com
Company type
Private
Founded year
2001
Operating status
Acquired
Headcount range
11–50 employees
Short description
GQ Life Sciences built GenomeQuest, an enterprise biological IP search platform covering 694+ million patent and non-patent sequences, serving pharmaceutical companies, government patent offices, and IP law firms. The company was acquired by Aptean and now operates as Aptean GenomeQuest.
Ownership category
akta.pro rank

GQ Life Sciences industry classification

Industry
Product category
Biological IP Search Software
NAICS
Software Publishers (5132), Web Search Portals and All Other Information Services (51929), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAJAN
Knowledge Management & Scientific Collaboration / Literature Intelligence
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Biological IP search
  • Sequence patent search
  • Genome prior art
  • Bioinformatics software
  • Patent sequence database

Where GQ Life Sciences is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Markets served

GQ Life Sciences business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Enterprise Software Licensing: Enterprise software licensing model for IP sequence search solution targeting pharmaceutical, biotechnology, and IP law organizations.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualQuote-based enterprise pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

GQ Life Sciences product offering

Product offering

Core offering

GQ Life Sciences develops and licenses GenomeQuest (now Aptean GenomeQuest), an enterprise biological IP search platform that indexes 694+ million sequences from both patent and non-patent sources. The software enables pharmaceutical, biotechnology, patent office, and IP law firm users to conduct comprehensive sequence-domain prior art, novelty, and freedom-to-operate searches with features such as Enhanced Keyword in Context and SEQ ID Highlighting.

Product overview

GQ Life Sciences redirects to Aptean GenomeQuest, a single unified product offering for comprehensive biological IP sequence search. The platform provides access to 694+ million sequences across patent and non-patent databases, featuring enhanced keyword context display and sequence ID highlighting capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • Aptean GenomeQuest (formerly GenomeQuest) Enterprise biological IP search platform providing comprehensive sequence-domain searching across 694+ million patent and non-patent sequences. Used by pharmaceutical and biotechnology companies, government patent offices, and IP law firms for prior art, novelty, freedom-to-operate, and patent validity analysis. Features include Enhanced Keyword in Context and SEQ ID Highlighting.

Quantifiable outcome

  • 694+ million sequences in database

Companies that use GQ Life Sciences

Customer profile

Named customers25 records

Segments3 records

Ideal customer profiles3 records

GQ Life Sciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

GQ Life Sciences partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

GQ Life Sciences competitors and assessment

Company assessment

Others

  • WIPO PATENTSCOPE: WIPO PATENTSCOPE is the international patent application's global search portal operated by the World Intellectual Property Organization. It is an adjacent ecosystem participant: a free public search tool that patent offices (including GenomeQuest customers) use alongside commercial platforms.

Direct peers

  • Minesoft: Minesoft provides PatentHub, PatBase, and MinePat enterprise patent search solutions serving patent attorneys, examiners, and corporate IP teams. It is a direct enterprise peer to GenomeQuest in the IP prior-art search category.
  • Questel: Questel offers Orbit Intelligence, an enterprise patent search and analytics suite directly comparable to GenomeQuest's biological IP search capabilities. Both serve IP attorneys, patent offices, and life sciences R&D teams with subscription-based prior-art and freedom-to-operate tools.
  • PatSnap: PatSnap is an AI-powered IP and R&D intelligence platform covering patents, sequences, and innovation analytics. It competes directly with GenomeQuest in pharma/biotech IP workflows and adds an emerging AI/ML layer that overlaps with GenomeQuest's prior-art and sequence-search use cases.

Emerging players

  • SureChem (Digital Science): SureChem (part of Digital Science) provides chemical patent search and structure-based IP analytics. It is an emerging player in the IP search market that overlaps with GenomeQuest's life sciences patent search focus, particularly for chemistry-adjacent biotech IP.
  • GeneCards: GeneCards is a comprehensive bioinformatics database of human genes maintained by the Weizmann Institute. It is an emerging, niche bioinformatics player adjacent to GenomeQuest's biological information focus, but does not target the IP/patent workflow directly.
  • NCBI BLAST: NCBI BLAST is the public-domain standard for biological sequence similarity search maintained by the National Library of Medicine. It is not focused on patent prior-art, but represents the baseline sequence search tool against which GenomeQuest's IP-enriched patent/non-patent corpus competes.

Broad incumbents

  • Clarivate: Clarivate is the dominant IP intelligence and scientific analytics platform (Derwent World Patents Index, PatentSight, Cortellis). It is a broad incumbent that competes with GenomeQuest across patent prior-art search and biotech IP analytics, but at significantly larger scale and a broader portfolio.
  • CAS (Chemical Abstracts Service): CAS, a division of ACS, provides SciFinder-n and related scientific information platforms with deep coverage of chemical, biological, and patent literature. It overlaps with GenomeQuest in serving pharma/biotech IP professionals searching large scientific corpora for prior art.
  • LexisNexis PatentAdvisor: LexisNexis IP (PatentAdvisor, PatentSight via Clarivate partnership, TotalPatent) provides patent search and analytics solutions to IP law firms and patent offices. It overlaps with GenomeQuest in freedom-to-operate, validity, and prior-art search workflows.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

GQ Life Sciences social profiles

Digital presence

GQ Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GQ Life Sciences leadership team

Management profile

Number of profiles

GQ Life Sciences funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GQ Life Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GQ Life Sciences

What does GQ Life Sciences do?

GQ Life Sciences develops and licenses GenomeQuest (now Aptean GenomeQuest), an enterprise biological IP search platform that indexes 694+ million sequences from both patent and non-patent sources. The software enables pharmaceutical, biotechnology, patent office, and IP law firm users to conduct comprehensive sequence-domain prior art, novelty, and freedom-to-operate searches with features such as Enhanced Keyword in Context and SEQ ID Highlighting.

Is GQ Life Sciences a public or private company?

GQ Life Sciences is a private company. It is classified as corporate owned and is currently acquired.

When was GQ Life Sciences founded?

GQ Life Sciences was founded in 2001. It employs 11 to 50 people.

Where is GQ Life Sciences based?

GQ Life Sciences is headquartered in Boston, United States, in the North America region.

How does GQ Life Sciences make money?

One revenue line is on record: enterprise Software Licensing.

Who are GQ Life Sciences's main competitors?

WIPO PATENTSCOPE is listed as an others. Direct peers are Minesoft, Questel and PatSnap. Emerging players are SureChem (Digital Science), GeneCards and NCBI BLAST. Broad incumbents are Clarivate, CAS (Chemical Abstracts Service) and LexisNexis PatentAdvisor.

Does GQ Life Sciences have an API?

No public API is recorded for GQ Life Sciences.

What industry is GQ Life Sciences in?

GQ Life Sciences's product category is Biological IP Search Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales